Clinical spectrum and outcome of hospitalized patients with invasive fungal infections: a prospective study from a medical ward/intensive care unit of a teaching hospital in North India.

Clinical spectrum and outcome of hospitalized patients with invasive fungal infections: a prospective study from a medical ward/intensive care unit of a teaching hospital in North India. Infez Med. 2019 Dec 01;27(4):398-402 Authors: Sindhu D, Jorwal P, Gupta N, Xess I, Singh G, Soneja M, Nischal N, Sethi P, Ray A, Biswas A, Wig N Abstract The aim of the study was to determine the clinical spectrum and outcome of invasive fungal infections (IFIs) in hospitalized patients. A prospective study was conducted in a teaching hospital in North India between December 2016 and December 2018. Patients diagnosed with IFIs were enrolled. Their clinical and laboratory parameters were recorded using a pre-defined clinical report form. They were followed up till discharge or death and a 60-day outcome was recorded. A total of 110 IFI cases were identified, which included invasive aspergillosis (39%), invasive candidiasis (16%), cryptococcosis (14%) and mucormycosis (12%). Pneumonia (63%) was the most common final diagnosis in these patients. Diabetes mellitus, chronic kidney disease and chronic obstructive pulmonary disease were the most common risk factor for all four diseases. Additionally, most patients with cryptococcosis had human immunodeficiency virus infection. Mortality was observed in 73% of the patients. Overall, IFIs are an important cause of morbidity and mortality in critically ill patients admitted to medical wards and ICUs. PMID: 31846989 [PubMed - in...
Source: Infezioni in Medicina - Category: Infectious Diseases Tags: Infez Med Source Type: research

Related Links:

Abstract COVID-19 has created enormous challenges for health systems worldwide, with the rapidly growing number of deaths and critical patients with pneumonia requiring ventilatory support. Alternative methods to control the spread of the disease such as social isolation, extreme quarantine measures, and contact tracing have been used around the world. However, these measures may not be totally effective to fight COVID-19, in step with the necessary national preparations to meet the new patient care demands. A wide range of digital technologies can be used to enhance these public health strategies, and the pandemi...
Source: Cadernos de Saude Publica - Category: International Medicine & Public Health Authors: Tags: Cad Saude Publica Source Type: research
CONCLUSIONS H19 expression in blood samples may be a novel marker of the diagnosis of nephrotic syndrome in children. PMID: 32489187 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
Authors: Al-Rawahi A PMID: 32489679 [PubMed]
Source: Oman Medical Journal - Category: Middle East Health Tags: Oman Med J Source Type: research
Authors: Yahaya TO, Ufuoma SB Abstract Single gene mutations have been implicated in the pathogenesis of a form of diabetes mellitus (DM) known as the maturity-onset diabetes of the young (MODY). However, there are diverse opinions on the suspect genes and pathophysiology, necessitating the need to review and communicate the genes to raise public awareness. We used the Google search engine to retrieve relevant information from reputable sources such as PubMed and Google Scholar. We identified 14 classified MODY genes as well as three new and unclassified genes linked with MODY. These genes are fundamentally embedde...
Source: Oman Medical Journal - Category: Middle East Health Tags: Oman Med J Source Type: research
Abstract Objective: Autoimmune conditions tend to cluster in subjects with Addison's disease (AD) and probably also among their relatives. The aim of the study was to estimate the frequency of the endocrine gland-specific autoantibodies in first-degree relatives of patients with AD. Methods: Autoantibodies were investigated in 113 family members using RIA and ELISA assays. The control group comprised 143 age-matched volunteers. Results: Autoimmune diseases were diagnosed in 38.1% relatives. Hashimoto's thyroiditis was found in 20.3%, Graves' disease in 8.0%, vitiligo and type 1 diabetes in 3.5%, whereas ...
Source: European Journal of Endocrinology - Category: Endocrinology Authors: Tags: Eur J Endocrinol Source Type: research
Fitbit is continuing its rapid trajectory into the medtech industry with a new Emergency Use Authorization from FDA. The San Francisco, CA-based company said the EUA is for a low-cost emergency ventilator to help address patients’ needs during the COVID-19 pandemic. The company said after seeing the need for ventilators, it applied its deep in-house expertise in advanced sensor development and hardware design to quickly create Fitbit Flow, an automatic resuscitator inspired by the MIT E-Vent Design Toolbox and based on specifications for Rapidly Manufactured Ventilation Systems. Fitbit said during develop...
Source: MDDI - Category: Medical Devices Tags: COVID-19 Business Source Type: news
Publication date: Available online 3 June 2020Source: Pharmacological ResearchAuthor(s): Ana Margarida da Silva Figueiredo, Ermelindo Carreira Leal, Eugénia Maria Lourenço de Carvalho
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 3 June 2020Source: Pharmacological ResearchAuthor(s): Peyman Nowrouzi-Sohrabi, Reza Tabrizi, Shahla Rezaei, Fatemeh Jafari, Kamran Hesami, Mehdi Abedi, Mohammad Jalali, Pedram Keshavarzi, Saeed Shahabi, Ali Asghar Kolahi, Kristin Carson-Chahhoud, Amirhossein Sahebkar, Saeid Safiri
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
Publication date: June 2020Source: Journal of the World Federation of Orthodontists, Volume 9, Issue 2Author(s): Vinod Krishnan
Source: Journal of the World Federation of Orthodontists - Category: Dentistry Source Type: research
Cardiovascular disease (CVD) is a major contributor to the morbidity and mortality associated with type 2 diabetes mellitus (T2DM). With T2DM growing in pandemic proportions, there will be profound healthcare implications of CVD in person with diabetes. The ideal drugs to improve outcomes in T2DM are those having antiglycemic efficacy in addition to cardiovascular (CV) safety, which has to be determined in appropriately designed CV outcome trials as mandated by regulatory agencies. Available evidence is largely supportive of metformin’s CV safety and potential CVD risk reduction effects, whereas sulfonylureas are eit...
Source: Cardiology in Review - Category: Cardiology Tags: Review Articles Source Type: research
More News: Aspergillosis | Chronic Kidney Disease | Chronic Obstructive Pulmonary | Cryptococcosis | Diabetes | Diabetes Mellitus | Endocrinology | Fungal Infections | Hospitals | India Health | Infectious Diseases | Intensive Care | Laboratory Medicine | Pneumonia | Study | Teaching | Teaching Hospitals | Universities & Medical Training | Urology & Nephrology